Anesthesia — Anesthetists After the Pandemic in the Eyes of the Public
Citation(s)
Onutu AH, Rus C, Acalovschi I The public perception of the anaesthesiologist in Romania: a survey. Rom J Anaesth Intensive Care. 2017 Apr;24(1):21-28. doi: 10.21454/rjaic.7518.241.onu.
Ribeiro CS, Mourao JI Anesthesiologist: the patient's perception. Braz J Anesthesiol. 2015 Nov-Dec;65(6):497-503. doi: 10.1016/j.bjane.2014.05.014. Epub 2015 Sep 28.
Sagun A, Birbicer H, Yapici G Patients', who applied to the anesthesia clinic, perceptions and knowledge about anesthesia in Turkiye. Saudi J Anaesth. 2013 Apr;7(2):170-4. doi: 10.4103/1658-354X.114076.
Swinhoe CF, Groves ER Patients' knowledge of anaesthetic practice and the role of anaesthetists. Anaesthesia. 1994 Feb;49(2):165-6. doi: 10.1111/j.1365-2044.1994.tb03380.x.
van Klei WA, Hollmann MW, Sneyd JR The value of anaesthesiologists in the COVID-19 pandemic: a model for our future practice? Br J Anaesth. 2020 Nov;125(5):652-655. doi: 10.1016/j.bja.2020.08.014. Epub 2020 Aug 20. No abstract available.
Whitty P, Goodwin D, Shaw IH Patients' perception of the anaesthetist and anaesthesia. Anaesthesia. 1994 Jul;49(7):644-5. doi: 10.1111/j.1365-2044.1994.tb14248.x. No abstract available.
Are Anesthetists Still Secret Heroes After the Pandemic?
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
